Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profiles

Fig. 1

Details of the candidates in the R&D pipeline for pre-eclampsia. Summary of the 153 candidates in the R&D pipeline for the prevention and treatment of pre-eclampsia from 2000 to 2021. The proportion of candidates A in active development, and inactive (no publications since 2018), B in each phase of the development pipeline C classified as drugs, dietary supplements or biologicals and D classified as new chemical or biological entities or repurposed drugs

Back to article page